Our Mission

Imagia’s mission is to leverage advances in artificial intelligence and accelerate the advent of accessible personalized medicine.

We believe that synergies between academia, institutions and commercial partners are a critical success factor in the quest towards precision medicine.

Our Story

Our co-founder Alexandre Le Bouthillier wanted to turn his personal loss to cancer into something positive. He founded Imagia with his long-time friend Nicolas Chapados by combining their extensive knowledge of AI and optimization, learned in their previous successful venture, to improve the future of medicine.

The pair, in collaboration with Professor Yoshua Bengio, the world-renowned co-father of deep learning, recruited a team of entrepreneurs, research scientists, developers, and clinical experts. They began exploring applications in computer vision and the quantitative mapping of clinical information to bring the power of deep learning to digitized health data and the company Imagia was born.

Leadership

Alexandre Le Bouthillier

Alexandre Le Bouthillier

Co-Founder and
Chief Corporate Officer
More info
Florent Chandelier

Florent Chandelier

Chief Technology Officer
More info
Geralyn Ochab

Geralyn Ochab

Interim CEO & CBO
More info
Anne-Marie Guertin

Anne-Marie Guertin

Chief Financial Officer, CPA, CA
More info
Nicolas Chapados

Nicolas Chapados

Co-Founder &
Chief AI Scientist
More info
Yoshua Bengio

Yoshua Bengio

Scientific Advisor
More info

Healthcare Leadership

Shelley Epstein

Shelley Epstein

Vice President - Corporate and Public Affairs
More info
Frank Rybicki

Frank Rybicki

Medical Director
More info
Christelle Fasano

Christelle Fasano

Senior Director , Business Development , Pharma & Biotech
More info
Kam Kafi

Kam Kafi

Director - Oncology and Clinical Strategy
More info
Jonathan Kanevsky

Jonathan Kanevsky

Director - Clinical Innovations
More info

Achievements

2019

January 2019

Imagia opens new office located in the AI epicenter of Montreal in the MILA building

May 2019

Federal Government Awards $49M to Imagia and the Terry Fox Research Institute led Consortium to Accelerate Medical Breakthroughs through the Digital Health and Discovery Platform (DHDP)

December 2019

Imagia Partners with Top US and Canadian Hospitals to Facilitate AI Accelerated Healthcare Discoveries

2018

February 2018

Imagia enters into a partnership agreement with Sciences In Vivo and the Institute for Research in Immunology and Cancer (IRIC).

March 2018

The Government of Quebec, through the BioMed Propulsion program, grants Imagia a $3 million loan.

May 2018

Imagia enters into a collaborative agreement with Olympus, through AI4GI, for the exclusive development of an AI solution for real-time clinical decision support during screening and colonoscopy surveillance procedures.

November 2018

Google mentioned Imagia in the annual report of its economic impact in Canada.

Imagia concludes a collaborative agreement with Christie Innomed.

December 2018

Imagia receives funding from Canada Economic Development for Quebec Regions (CED).

2017

February 2017

Imagia ranks as one of the world’s best AI start-ups transforming healthcare according to CBInsights.

November 2017

Imagia acquires Cadens Medical Imaging Inc.

2016

December 2016

Series A financing led by BDC Healthcare Venture Fund and joined by Fidelity Investments Canada ULC.

2015

January 2015

Long-time friends Alexandre Le Bouthillier and Nicolas Chapados launch Imagia, supported by one of the three fathers of deep learning, Prof Yoshua Bengio.